Northern Ireland will begin offering the MenB vaccine to young people starting 31 July 2026, following an outbreak in England where two individuals died. The program targets Year 14 students and under-25s beginning university or higher education for the first time. The vaccine is intended to protect against meningitis B, a severe bacterial infection spread through close contact. Eligible groups include those born between 2 July 2007 and 1 July 2008, and those starting university in the UK or Ireland. The vaccine requires two doses spaced 28 days apart. Similar programs are being implemented in England, Wales, and Scotland.
Bias read (Center): The article presents factual information about a public health initiative without overtly favoring any political ideology. It provides balanced reporting on the vaccination program, its eligibility criteria, and the reasons behind its implementation, without emphasizing partisan perspectives.




